These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 163941)

  • 1. Fasting serum bile acid levels in the primary hyperlipoproteinemias.
    Korman MG; Ellefson RD; Hofmann AF
    Mayo Clin Proc; 1975 Feb; 50(2):76-8. PubMed ID: 163941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;
    Einarsson K; Hellström K; Kallner M
    J Clin Invest; 1974 Dec; 54(6):1301-11. PubMed ID: 4373491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size.
    Angelin B; Bjökhem I; Einarsson K
    J Lipid Res; 1978 Jul; 19(5):527-37. PubMed ID: 670831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual serum bile aids in patients with primary hyperlipoproteinemias.
    Angelico M; Angelico F; Amodeo P; Attili AF; Puoti C; Ricci G; Capocaccia L
    Atherosclerosis; 1980 Oct; 37(2):293-9. PubMed ID: 7426102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral steroid excretion in patients with hyperlipoproteinemia types II and IV.
    Kallner M
    J Lab Clin Med; 1975 Oct; 86(4):595-604. PubMed ID: 170347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.
    Jones GJ; Hewitt D; Godin GJ; Breckenridge WC; Bird J; Mishkel MA; Steiner G; Little JA
    Can Med Assoc J; 1980 Jan; 122(1):37-8, 40-6. PubMed ID: 7363194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in the development of radioimmunoassays for human serum lipoproteins.
    Karlin JB; Juhn DJ; Goldberg R; Rubenstein AH
    Ann Clin Lab Sci; 1978; 8(2):142-54. PubMed ID: 205163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestyramine treatment reduces postprandial but not fasting serum bile acid levels in humans.
    Angelin B; Björkhem I; Einarsson K; Ewerth S
    Gastroenterology; 1982 Nov; 83(5):1097-101. PubMed ID: 7117793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
    Olsson AG; Ekelund LG; Carlson LA
    Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J; Sezille G; Dewailly P; Fruchart JC
    Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.
    Pertsemlidis D; Panveliwalla D; Ahrens EH
    Gastroenterology; 1974 Apr; 66(4):565-73. PubMed ID: 4821079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary lipid composition in normo- and hyperlipoproteinemia.
    Ahlberg J; Angelin B; Einarsson K; Hellström K; Leijd B
    Gastroenterology; 1980 Jul; 79(1):90-4. PubMed ID: 7380228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
    Einarsson K; Hellström K; Leijd B
    J Lab Clin Med; 1977 Oct; 90(4):613-22. PubMed ID: 198500
    [No Abstract]   [Full Text] [Related]  

  • 17. Postprandial serum bile acids in resected and non-resected patients with Crohn's disease.
    Heuman R; Sjödahl R; Tobiasson P; Tagesson C
    Scand J Gastroenterol; 1982 Jan; 17(1):137-40. PubMed ID: 7134829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
    Klemens UH; von Löwis P
    Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an intravenous bile acid tolerance test. Plasma disappearance of cholylglycine in health.
    Korman MG; LaRusso NF; Hoffman NE; Hofmann AF
    N Engl J Med; 1975 Jun; 292(23):1205-9. PubMed ID: 1128571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.